Coronavirus Spike Glycoprotein (CoV S) Peptid
Kurzübersicht für Coronavirus Spike Glycoprotein (CoV S) Peptid (ABIN6952488)
Target
Spezies
Quelle
Applikation
- 
    - 
                                            Sequenz
- SLDQINVTFL DLEYEMKKLE EAIKKLEESY IDLKEL
- 
                                            Produktmerkmale
- EK1 / Pan-HCoV S Inhibitor
- 
                                            Reinheit
- ≥ 95 %
- 
                                            Bestandteile
- Each vial contains 100 μg of NET peptide.
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Powder
- 
                                            Lagerung
- RT,4 °C,-20 °C
- 
                                            Informationen zur Lagerung
- Up to 6 months in lyophilized form at 0-5°C. For best results, rehydrate just before use. After rehydration, keep solution at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles.
 
- 
                                            
- 
    - 
                                            : "Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein."    in: Cellular & molecular immunology, (2020)         (PubMed).        
 : "Drug treatment options for the 2019-new coronavirus (2019-nCoV)." in: Bioscience trends, Vol. 14, Issue 1, pp. 69-71, (2020) (PubMed).
 : "A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike." in: Science advances, Vol. 5, Issue 4, pp. eaav4580, (2019) (PubMed).
 
 
- 
                                            : "Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein."    in: Cellular & molecular immunology, (2020)         (PubMed).        
- 
    - Coronavirus Spike Glycoprotein (CoV S)
- 
                                            Substanzklasse
- Viral Protein
- 
                                            Molekulargewicht
- 4332
 Target
- 
                    
 
                                     
                                     
                                    